Cargando…

Animal Models for Sars

Detalles Bibliográficos
Autores principales:	Roberts, Anjeanette, Subbarao, Kanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2006
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123016/ https://www.ncbi.nlm.nih.gov/pubmed/17037579 http://dx.doi.org/10.1007/978-0-387-33012-9_83

Ejemplares similares

Is there an ideal animal model for SARS?
por: Subbarao, Kanta, et al.
Publicado: (2006)

Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25–26 August 2005, London, UK
por: Roberts, Anjeanette, et al.
Publicado: (2006)

Animal models and vaccines for SARS-CoV infection
por: Roberts, Anjeanette, et al.
Publicado: (2008)

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
por: Bisht, Himani, et al.
Publicado: (2005)

Animal models for SARS and MERS coronaviruses
por: Gretebeck, Lisa M, et al.
Publicado: (2015)

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
por: Kapadia, Sagar U., et al.
Publicado: (2005)

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
por: Yang, Zhi-yong, et al.
Publicado: (2004)

Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
por: Sutton, Troy C., et al.
Publicado: (2015)

SARS Vaccine Protective in Mice
por: Stadler, Konrad, et al.
Publicado: (2005)

The Role of Animal Models In Influenza Vaccine Research
por: Luke, Catherine J., et al.
Publicado: (2010)

The role of animal models in influenza vaccine research
por: Luke, Catherine J., et al.
Publicado: (2008)

Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
por: Vogel, Leatrice N., et al.
Publicado: (2007)

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys
por: McAuliffe, Josephine, et al.
Publicado: (2004)

The Critical Interspecies Transmission Barrier at the Animal–Human Interface
por: Subbarao, Kanta
Publicado: (2019)

SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism
por: Frieman, Matthew B., et al.
Publicado: (2010)

A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
por: Roberts, Anjeanette, et al.
Publicado: (2007)

The success of SARS-CoV-2 vaccines and challenges ahead
por: Subbarao, Kanta
Publicado: (2021)

SARS-CoV-2: A New Song Recalls an Old Melody
por: Subbarao, Kanta
Publicado: (2020)

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
por: Khoury, David S., et al.
Publicado: (2020)

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro
por: Kam, Yiu Wing, et al.
Publicado: (2007)

Advances in Influenza Virus Research: A Personal Perspective
por: Subbarao, Kanta
Publicado: (2018)

Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
por: Darnell, Miriam E.R., et al.
Publicado: (2004)

Scientific barriers to developing vaccines against avian influenza viruses
por: Subbarao, Kanta, et al.
Publicado: (2007)

Respiratory Virus Infections: Understanding COVID-19
por: Subbarao, Kanta, et al.
Publicado: (2020)

H5N1 Viruses and Vaccines
por: Subbarao, Kanta, et al.
Publicado: (2007)

SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice
por: Baz, Mariana, et al.
Publicado: (2022)

Vaccines for Pandemic Influenza
por: Luke, Catherine J., et al.
Publicado: (2006)

Can Immunity Induced by the Human Influenza Virus N1 Neuraminidase Provide Some Protection from Avian Influenza H5N1 Viruses?
por: Gillim-Ross, Laura, et al.
Publicado: (2007)

Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model
por: Koszalka, Paulina, et al.
Publicado: (2022)

Preclinical and clinical developments for combination treatment of influenza
por: Koszalka, Paulina, et al.
Publicado: (2022)

Respiratory Virus Vaccines
por: Broadbent, Andrew J., et al.
Publicado: (2015)

Immune imprinting and SARS-CoV-2 vaccine design
por: Wheatley, Adam K., et al.
Publicado: (2021)

Engineering H5N1 avian influenza viruses to study human adaptation
por: Morens, David M., et al.
Publicado: (2012)

Idiopathic Anaphylaxis: A Diagnosis of Exclusion
por: Mendez, Anjeanette, et al.
Publicado: (2021)

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
por: Bukreyev, Alexander, et al.
Publicado: (2004)

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
por: Traggiai, Elisabetta, et al.
Publicado: (2004)

Animal models for SARS-CoV-2
por: Lee, Chung-Young, et al.
Publicado: (2021)

SARS-CoV-2 in animals: From potential hosts to animal models
por: Michelitsch, Anna, et al.
Publicado: (2021)

Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases
por: Kumari, Madhulata, et al.
Publicado: (2021)

Animal models of SARS-CoV-2 transmission
por: de Vries, Rory D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aucgnpk7uqvis5g9gb4huipe15